Inventor · disambiguated record
Curtis Wright
Also filed as: WRIGHT CURTIS · WRIGHT CURTIS M · WRIGHT IV CURTIS
90 granted patents·49 pending applications·3,595 citations·filing 1984–2022
99Inventor score
Top patents by PatentIndex Score
139 records- 0199US9387174B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jul 12, 2016·26 cites·22 claims
- 0299US9387173B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Jul 12, 2016·27 cites·22 claims
- 0399US9060976B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2012·Granted Jun 23, 2015·72 cites·1 claims
- 0499US9044435B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted Jun 2, 2015·55 cites·20 claims
- 0599US9040084B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted May 26, 2015·38 cites·9 claims
- 0699US9034376B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted May 19, 2015·48 cites·19 claims
- 0799US8999961B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Apr 7, 2015·41 cites·8 claims
- 0899US8871265B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2014·Granted Oct 28, 2014·51 cites·13 claims
- 0999US8609683B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Dec 17, 2013·85 cites·22 claims
- 1099US8529948B1Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Sep 10, 2013·80 cites·22 claims
- 1199US8524275B2Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agentOSHLACK BENJAMIN·Filed 2010·Granted Sep 3, 2013·92 cites·27 claims
- 1299US8389007B2Pharmaceutical composition containing gelling agentWRIGHT CURTIS·Filed 2008·Granted Mar 5, 2013·94 cites·20 claims
- 1399US8337888B2Pharmaceutical formulation containing gelling agentWRIGHT CURTIS·Filed 2012·Granted Dec 25, 2012·198 cites·24 claims
- 1499US7842307B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agentPURDUE PHARMA LP·Filed 2002·Granted Nov 30, 2010·221 cites·43 claims
- 1599US7658939B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2003·Granted Feb 9, 2010·176 cites·24 claims
- 1699US7144587B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agentEURO CELTIQUE SA·Filed 2002·Granted Dec 5, 2006·216 cites·22 claims
- 1799US7141250B2Pharmaceutical formulation containing bittering agentPURDUE PHARMA LP·Filed 2002·Granted Nov 28, 2006·224 cites·38 claims
- 1899US6716449B2Controlled-release compositions containing opioid agonist and antagonistEURO CELTIQUE SA·Filed 2001·Granted Apr 6, 2004·252 cites·10 claims
- 1999US6696088B2Tamper-resistant oral opioid agonist formulationsEURO CELTIQUE SA·Filed 2001·Granted Feb 24, 2004·456 cites·40 claims
- 2098US9308171B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Apr 12, 2016·25 cites·24 claims
- 2198US9308170B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2013·Granted Apr 12, 2016·24 cites·17 claims
- 2298US6682757B1Titratable dosage transdermal delivery systemEURO CELTIQUE SA·Filed 2000·Granted Jan 27, 2004·176 cites·29 claims
- 2397US8465774B2Sequestered antagonist formulationsBREDER CHRISTOPHER·Filed 2006·Granted Jun 18, 2013·52 cites·137 claims
- 2497US7790215B2Sustained-release gel coated compositionsPURDUE PHARMA LP·Filed 2003·Granted Sep 7, 2010·89 cites·77 claims
- 2596US10206881B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2017·Granted Feb 19, 2019·7 cites·7 claims
- 2696US9872836B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 23, 2018·8 cites·24 claims
- 2796US9693961B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jul 4, 2017·7 cites·17 claims
- 2896US9101668B2Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agentPURDUE PHARMA LP·Filed 2013·Granted Aug 11, 2015·12 cites·22 claims
- 2996US7842311B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2003·Granted Nov 30, 2010·52 cites·67 claims
- 3096US7384653B2Oral dosage form comprising a therapeutic agent and an adverse-effect agentPURDUE PHARMA LP·Filed 2004·Granted Jun 10, 2008·89 cites·39 claims
- 3195US10076497B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 18, 2018·6 cites·22 claims
- 3295US10071057B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 11, 2018·6 cites·25 claims
- 3395US10064824B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 4, 2018·6 cites·26 claims
- 3495US9517207B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2015·Granted Dec 13, 2016·6 cites·24 claims
- 3595US9289397B2Titratable dosage transdermal delivery systemPURDUE PHARMA LP·Filed 2014·Granted Mar 22, 2016·22 cites·20 claims
- 3695US8357399B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2012·Granted Jan 22, 2013·17 cites·22 claims
- 3795US8236351B2Tamper-resistant oral opioid agonist formulationsOSHLACK BENJAMIN·Filed 2010·Granted Aug 7, 2012·19 cites·39 claims
- 3895US7846476B2Once-a-day oxycodone formulationsPURDUE PHARMA LP·Filed 2002·Granted Dec 7, 2010·63 cites·17 claims
- 3995US7718192B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2003·Granted May 18, 2010·41 cites·17 claims
- 4095US7682632B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2003·Granted Mar 23, 2010·41 cites·15 claims
- 4194US8586088B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2012·Granted Nov 19, 2013·13 cites·24 claims
- 4294US8518443B2Opioid agonist formulations with releasable and sequestered antagonistBREDER CHRISTOPHER·Filed 2012·Granted Aug 27, 2013·22 cites·21 claims
- 4394US8231901B2Opioid agonist formulations with releasable and sequestered antagonistBREDER CHRISTOPHER·Filed 2011·Granted Jul 31, 2012·20 cites·20 claims
- 4494US7914818B2Opioid agonist formulations with releasable and sequestered antagonistPURDUE PHARMA LP·Filed 2002·Granted Mar 29, 2011·46 cites·21 claims
- 4593US9877924B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Jan 30, 2018·4 cites·19 claims
- 4693US9757341B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2016·Granted Sep 12, 2017·4 cites·20 claims
- 4793US7842309B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2003·Granted Nov 30, 2010·28 cites·22 claims
- 4892US10064825B2Pharmaceutical formulation containing gelling agentPURDUE PHARMA LP·Filed 2017·Granted Sep 4, 2018·3 cites·13 claims
- 4990US9034377B2Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose CmaxPURDUE PHARMA LP·Filed 2014·Granted May 19, 2015·19 cites·24 claims
- 5090US8936812B2Tamper-resistant oral opioid agonist formulationsPURDUE PHARMA LP·Filed 2013·Granted Jan 20, 2015·6 cites·20 claims
Showing the top 50 of 139 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →